“The mRNA was a technology that we had less experience, only two years working with this. And actually mRNA was a technology that never delivered a single product until that day – not vaccine, not any other medicine. So it was very counterintuitive and I was surprised when they suggested to me that this is the way to go…” Albert Bourla, Pfizer CEO